GlassScriptPhysician profile
Laxman Prajapat
NPI 1265699912
$8,046.60
in general payments reported to CMS, 2019-2025
35 companies · $964 in 2025
The $964 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,095 · 2020: $276 · 2021: $812 · 2022: $566 · 2023: $747 · 2024: $2,587 · 2025: $964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,298 · Consulting Fee: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,297.96 |
| Consulting Fee | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,061.73 | 2023-2024 | Ensite Precision, Gallant |
| Medtronic Vascular, INC. | $1,056.45 | 2019 | |
| Abiomed | $555.39 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $540.52 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $387.96 | 2019-2025 | Lokelma, Farxiga |
| Novartis Pharmaceuticals Corporation | $356.78 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $308.11 | 2019-2025 | Lifevest |
| Medtronic, INC. | $303.63 | 2022-2025 | Corevalve Evolut R |
| Pfizer INC. | $284.45 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $275.69 | 2019-2022 | |
| Boston Scientific Corporation | $258.21 | 2019-2023 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $236.09 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $230.25 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $211.82 | 2019-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $204.44 | 2023-2025 | Optimizer, Optimizer |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laxman Prajapat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.